Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia
Launched by BRITISH COLUMBIA CANCER AGENCY · Jan 25, 2008
Trial Information
Current as of May 07, 2025
Completed
Keywords
ClinConnect Summary
OBJECTIVES:
* To identify potential improvements for a noninvasive method of diagnosing cervical dysplasia and neoplasia using digital colposcopy and fluorescence spectroscopic imaging.
* To measure fluorescence and reflectance images of the human cervix in vivo using digital colposcopy.
* To evaluate the effect of acetic acid on the image contrast obtained.
* To compare the device performance with colposcopic impression and histopathologic interpretation of tissue removed by standard loop electrosurgical excision procedure (LEEP).
OUTLINE: This is a multicenter study.
Participants under...
Gender
FEMALE
Eligibility criteria
- Criteria:
- Inclusion criteria:
- • Included subjects will be ≥18 years old.
- • Included subjects will not be pregnant.
- • Included subjects will have a negative urine pregnancy test.
- • Included subjects will be scheduled for colposcopy and/or LEEP treatment at the VGH Women's Clinic.
- • Included subjects will indicate understanding of the study.
- • Included subjects will provide informed consent to participate.
- Exclusion criteria:
- • Individuals \<18 years old will be excluded.
- • Pregnant individuals will be excluded.
- • Individuals that have had an operation to remove their cervix will be excluded.
- PRIOR CONCURRENT THERAPY:
- • See Disease Characteristics
About British Columbia Cancer Agency
The British Columbia Cancer Agency (BCCA) is a leading organization dedicated to cancer research, treatment, and prevention in Canada. As a prominent clinical trial sponsor, BCCA focuses on advancing cancer care through innovative research and the development of new therapeutic strategies. With a commitment to improving patient outcomes, BCCA collaborates with a network of healthcare professionals and research institutions to conduct rigorous clinical trials that explore cutting-edge treatments and diagnostic methods. Their multidisciplinary approach, combined with a strong emphasis on patient-centered care, positions BCCA at the forefront of cancer research and healthcare advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Dianne M. Miller, M.D.
Principal Investigator
British Columbia Cancer Agency, Vancouver General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials